Division of Cardiology, Tokai University School of Medicine, Isehara, Japan.
Eur Heart J Acute Cardiovasc Care. 2017 Oct;6(7):623-631. doi: 10.1177/2048872616633850. Epub 2016 Feb 15.
In ST-elevation myocardial infarction (STEMI) patients with diffuse ectatic coronary artery, extensive thrombi inhibit achievement of final successful revascularization of Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow after primary percutaneous coronary intervention. However, clinical and angiographic outcomes of such patients are uncertain. The present study examined clinical and angiographic outcomes in STEMI incorporating giant coronary artery with diffuse ectasia.
Seven hundred and forty-four STEMI patients undergoing primary percutaneous coronary intervention were surveyed retrospectively. Culprit lesions in giant coronary artery with diffuse ectasia (Ectatic group, n=39) were investigated. Percutaneous coronary intervention success rate and angiographic or clinical outcomes at 360 days were compared with those of the Non-ectatic group ( n=705).
Angiographic percutaneous coronary intervention success rate was significantly lower in the Ectatic group due to lower achievement of final TIMI grade 3 flow (53.8% vs. 92.9%, p<0.0001; 53.8% vs. 93.5%, p<0.0001, respectively). In follow-up angiography, 86% of the Ectatic group showed angiographic improvement from TIMI grade 2 or less immediately after percutaneous coronary intervention to TIMI grade 3 flow at follow-up. In contrast, angiographic improvement was observed in only 25% of cases in the Non-ectatic group. All-cause 360-day mortality was significantly lower in the ectatic group (2.6% vs. 14.5%, p=0.0361, respectively).
In patients with STEMI in giant coronary artery with diffuse ectasia, achievement of TIMI grade 3 flow was significantly reduced immediately after percutaneous coronary intervention. However, improvement of coronary flow up to TIMI grade 3 was not uncommon at follow-up angiogram. Patients had low mortality despite low TIMI grade 3 achievement immediately after primary percutaneous coronary intervention.
在原发性经皮冠状动脉介入治疗(PCI)后发生 ST 段抬高型心肌梗死(STEMI)的弥漫性扩张型冠状动脉患者中,广泛的血栓形成阻碍了达到血栓溶解治疗心肌梗死(TIMI)血流 3 级的最终成功再血管化。然而,此类患者的临床和血管造影结果并不确定。本研究探讨了合并巨大冠状动脉弥漫性扩张的 STEMI 患者的临床和血管造影结果。
回顾性调查了 744 例接受原发性 PCI 的 STEMI 患者。研究了巨大冠状动脉弥漫性扩张病变中的罪犯病变(扩张组,n=39)。比较了扩张组和非扩张组(n=705)在 360 天的经皮冠状动脉介入治疗成功率和血管造影或临床结果。
由于最终 TIMI 血流 3 级的获得率较低,扩张组的血管造影经皮冠状动脉介入治疗成功率明显较低(53.8% vs. 92.9%,p<0.0001;53.8% vs. 93.5%,p<0.0001)。在随访血管造影中,扩张组 86%的患者从即刻 PCI 后 TIMI 血流 2 级或更低水平改善至随访时的 TIMI 血流 3 级。相比之下,非扩张组只有 25%的患者出现血管造影改善。扩张组的全因 360 天死亡率明显较低(2.6% vs. 14.5%,p=0.0361)。
在巨大冠状动脉弥漫性扩张的 STEMI 患者中,即刻 PCI 后 TIMI 血流 3 级的获得率明显降低。然而,在随访血管造影中,冠状动脉血流改善至 TIMI 血流 3 级并不少见。尽管即刻 PCI 后 TIMI 血流 3 级获得率较低,但患者死亡率较低。